Si Yang

1.0k total citations
43 papers, 702 citations indexed

About

Si Yang is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Si Yang has authored 43 papers receiving a total of 702 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 12 papers in Cancer Research and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Si Yang's work include RNA modifications and cancer (11 papers), Cancer-related molecular mechanisms research (7 papers) and RNA Research and Splicing (6 papers). Si Yang is often cited by papers focused on RNA modifications and cancer (11 papers), Cancer-related molecular mechanisms research (7 papers) and RNA Research and Splicing (6 papers). Si Yang collaborates with scholars based in China, United Kingdom and United States. Si Yang's co-authors include Zhijun Dai, Yujiao Deng, Wen G. Jiang, Weijin Zang, Xiao‐Jiang Yu, Yi Zheng, Shan Cheng, Jia Yao, Lijuan Lyu and Hefen Yu and has published in prestigious journals such as Scientific Reports, The FASEB Journal and Free Radical Biology and Medicine.

In The Last Decade

Si Yang

43 papers receiving 700 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Si Yang China 17 455 206 109 95 58 43 702
Esra Göv Türkiye 14 536 1.2× 175 0.8× 138 1.3× 83 0.9× 43 0.7× 38 790
Yan-qing Ding China 18 456 1.0× 172 0.8× 52 0.5× 188 2.0× 17 0.3× 71 747
Markus Haak Germany 14 406 0.9× 68 0.3× 62 0.6× 74 0.8× 56 1.0× 23 733
Mengxuan Xia China 8 448 1.0× 220 1.1× 110 1.0× 87 0.9× 18 0.3× 9 668
Harika Sabbineni United States 12 344 0.8× 94 0.5× 98 0.9× 78 0.8× 15 0.3× 16 535
Zhiqin Xie China 19 816 1.8× 285 1.4× 69 0.6× 104 1.1× 19 0.3× 58 1.2k
Ashish Saroha India 15 313 0.7× 104 0.5× 97 0.9× 71 0.7× 53 0.9× 18 561
Laura D’Ignazio United Kingdom 8 273 0.6× 283 1.4× 83 0.8× 68 0.7× 17 0.3× 10 641

Countries citing papers authored by Si Yang

Since Specialization
Citations

This map shows the geographic impact of Si Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Si Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Si Yang more than expected).

Fields of papers citing papers by Si Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Si Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Si Yang. The network helps show where Si Yang may publish in the future.

Co-authorship network of co-authors of Si Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Si Yang. A scholar is included among the top collaborators of Si Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Si Yang. Si Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Shanshan, Ting Guo, Hui Zhang, et al.. (2023). ZNF281 inhibits mitochondrial biogenesis to facilitate metastasis of hepatocellular carcinoma. Cell Death Discovery. 9(1). 396–396. 12 indexed citations
2.
Wang, Shanshan, Liyong Wang, Si Yang, et al.. (2023). Inhibition of Annexin A10 Contributes to ZNF281 Mediated Aggressiveness of Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma. Volume 10. 553–571. 7 indexed citations
3.
Zheng, Yi, Si Yang, Yujiao Deng, et al.. (2022). BMPR1B Polymorphisms (rs1434536 and rs1970801) are Associated With Breast Cancer Susceptibility in Northwest Chinese Han Females: A Case-Control Study. Clinical Breast Cancer. 22(5). e641–e646. 4 indexed citations
4.
Ba, Yue, et al.. (2022). Association of oxidative stress and Kashin–Beck disease integrated Meta and Bioinformatics analysis. Osteoarthritis and Cartilage. 30(12). 1606–1615. 8 indexed citations
5.
Yang, Si, Bowen Yao, Liming Wu, et al.. (2021). Ubiquitin-related molecular classification and risk stratification of hepatocellular carcinoma. Molecular Therapy — Oncolytics. 21. 207–219. 6 indexed citations
6.
Yang, Si, Shuai Lin, Kang Liu, et al.. (2021). Identification of an immune-related RNA-binding protein signature to predict survival and targeted therapy responses in liver cancer. Genomics. 113(2). 795–804. 11 indexed citations
7.
Zhang, Dai, Yi Zheng, Si Yang, et al.. (2021). Identification of a Novel Glycolysis-Related Gene Signature for Predicting Breast Cancer Survival. Frontiers in Oncology. 10. 596087–596087. 21 indexed citations
9.
Huang, Jing, Mu Hu, Huan Niu, et al.. (2021). Osteopontin isoform c promotes the survival of cisplatin-treated NSCLC cells involving NFATc2-mediated suppression on calcium-induced ROS levels. BMC Cancer. 21(1). 750–750. 6 indexed citations
10.
Deng, Yujiao, Linghui Zhou, Jia Yao, et al.. (2020). Associations of lncRNA H19 Polymorphisms at MicroRNA Binding Sites with Glioma Susceptibility and Prognosis. Molecular Therapy — Nucleic Acids. 20. 86–96. 28 indexed citations
11.
Lyu, Lijuan, Yi Zheng, Tian Tian, et al.. (2020). <p>Overexpression of <em>FAM234B</em> Predicts Poor Prognosis in Patients with Luminal Breast Cancer</p>. Cancer Management and Research. Volume 12. 12457–12471. 6 indexed citations
12.
Lü, Yabin, Ran Zhang, Jing Wang, et al.. (2019). A Generic Method for Fast and Sensitive Detection of Adeno-Associated Viruses Using Modified AAV Receptor Recombinant Proteins. Molecules. 24(21). 3973–3973. 5 indexed citations
13.
Huang, Jing, Siyuan Chang, Yabin Lü, et al.. (2019). Enhanced osteopontin splicing regulated by RUNX2 is HDAC-dependent and induces invasive phenotypes in NSCLC cells. Cancer Cell International. 19(1). 306–306. 20 indexed citations
14.
Xue, Run‐Qing, Xiao‐Jiang Yu, Ming Zhao, et al.. (2019). Pyridostigmine alleviates cardiac dysfunction via improving mitochondrial cristae shape in a mouse model of metabolic syndrome. Free Radical Biology and Medicine. 134. 119–132. 27 indexed citations
15.
Xue, Run‐Qing, Ming Zhao, Qing Wu, et al.. (2019). Regulation of mitochondrial cristae remodelling by acetylcholine alleviates palmitate-induced cardiomyocyte hypertrophy. Free Radical Biology and Medicine. 145. 103–117. 31 indexed citations
16.
Xue, Run‐Qing, Xijing He, Ming Zhao, et al.. (2019). Cholinergic drugs ameliorate endothelial dysfunction by decreasing O-GlcNAcylation via M3 AChR-AMPK-ER stress signaling. Life Sciences. 222. 1–12. 17 indexed citations
17.
Yang, Xiaomei, Guifang Du, Si Yang, et al.. (2017). A Novel NHERF1 Mutation in Human Breast Cancer and Effects on Malignant Progression. Anticancer Research. 37(1). 67–74. 11 indexed citations
18.
Yang, Si, et al.. (2017). Synergistic Effects of SAM and Selenium Compounds on Proliferation, Migration and Adhesion of HeLa Cells. Anticancer Research. 37(8). 4433–4441. 14 indexed citations
19.
20.
Gött, Peter, Lothar Zöller, Si Yang, et al.. (1991). Antigenicity of hantavirus nucleocapsid proteins expressed in E. coli. Virus Research. 19(1). 1–15. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026